1. Home
  2. NICE guidance
  3. In development

Neuroendocrine tumours (metastatic, unresectable, progressive) - everolimus and sunitinib [ID858]

In development [GID-TA10024] Expected publication date: 28 June 2017

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 335 KB 12 May 2017  
  • Public committee slides PDF 897 KB 12 May 2017  
  • Public committee slides PDF 447 KB 12 May 2017  
  • Committee papers PDF 15.49 MB 12 May 2017  

Invitation to participate

  • Final matrix PDF 101 KB 02 June 2016  
  • Final protocol PDF 351 KB 27 June 2016  
  • Final scope PDF 112 KB 18 August 2016  
  • NICE's response to comments on the draft scope and provisional matrix PDF 134 KB 18 August 2016  

Draft scope documents

  • Draft scope (post-referral) PDF 147 KB 29 February 2016  
  • Provisional matrix (post-referral) PDF 100 KB 29 February 2016